News | Radiation Oncology | June 30, 2015

Southeast India facility reaches milestone in just six years, taking many pro bono cases

Varian, RapidArc, Yashoda Hospital, Hyderabad, India, 10,000th patient

June 30, 2015 - A three-year-old baby girl with a brain tumor has become the 10,000th patient at Yashoda Hospital in Hyderabad, India to be treated using RapidArc radiotherapy technology from Varian Medical Systems.

The treatment comes just six years after RapidArc was first introduced clinically at the private hospital, which treats more than 4,000 patients a year from the states of Telangana and Andhra Pradesh in the south-east of India. "The patient responded well to the treatment," said G. S. Rao, M.D., director of the Yashoda group of hospitals.

Yashoda was the first hospital in India to introduce RapidArc treatments, and over the past six years it has phased out the use of 'static-field' intensity modulated radiotherapy (IMRT) treatments and replaced them with RapidArc. In so doing, it has become the first hospital to reach the landmark of 10,000 RapidArc treatments.

Varian's RapidArc technology delivers fast and precise radiotherapy treatments in single or multiple rotations of the treatment machine around the patient. Faster treatments allow for greater precision, since there is less chance of patient or tumor movement during treatment delivery, and the patient spends less time on the treatment couch.

Over half the RapidArc treatments carried out at Yashoda over the past six years have involved tumors of the brain, head and neck. Three Varian linear accelerators at the hospital are equipped with RapidArc technology, which was introduced by Varian to speed up treatments and make advanced IMRT approaches more widely available to cancer patients globally.

"We see RapidArc as a very efficient and precise way of delivering advanced radiotherapy," said Rao. "Because of the speed of RapidArc treatments, we no longer have a waiting list. In fact, we usually start treatments within two days of the patients being taken for CT [computed tomography] simulation."

Although Yashoda is a private cancer center, it has a strong history of delivering treatments 'pro bono' for those who cannot afford advanced radiotherapy. About of a fifth of the center's RapidArc treatments have fallen into this category. Indeed, for several years it has sent a bus into local villages several times a month and brought patients back to Hyderabad for treatment. The bus, equipped with a wide range of diagnostic equipment, travels to remote villages throughout the province of Andhra Pradesh and screens patients for cancer. If people need treatment, they are brought back to the hospital and treated without charge.

For more information: www.varian.com


Related Content

News | Stereotactic Body Radiation Therapy (SBRT)

Sept. 27, 2026 — Siemens Healthineers recently launched Accela, a radiotherapy solution engineered around NeoArc ...

Time October 01, 2026
arrow
News | ASTRO

Sept. 29, 2026 — The American Society for Radiation Oncology (ASTRO) has named Siemens Healthineers the inaugural ...

Time September 29, 2026
arrow
News | Proton Therapy

Sept. 28, 2026 — Penn Medicine and Ion Beam Applications (IBA) have formed Noventra Oncology Alliance, a new joint ...

Time September 28, 2026
arrow
News | ASTRO

Sept. 22, 2026 — Leading experts in radiation therapy from the Abramson Cancer Center (ACC) of the University of ...

Time September 24, 2026
arrow
News | ASTRO

Sept.16, 2026 — For appropriately selected patients with muscle-invasive bladder cancer, preserving the bladder can be a ...

Time September 17, 2026
arrow
News | Radiology Imaging

Sept. 1, 2026 — Leo Cancer Care and GE HealthCare have announced that the two companies intend to work together on GE ...

Time September 11, 2026
arrow
News | ASTRO

Sept. 9, 2026 — The 2026 American Society for Radiation Oncology (ASTRO) Annual Meeting, will take place Sept. 26 to 30 ...

Time September 11, 2026
arrow
News | Radiation Oncology

Sept. 2, 2026 — Children with one of the deadliest forms of brain cancer may benefit from an additional course of ...

Time September 03, 2026
arrow
News | Radiation Therapy

Aug. 13, 2026 — An updated clinical guideline from the American Society for Radiation Oncology (ASTRO) provides evidence ...

Time August 17, 2026
arrow
News | Prostate Cancer

Aug. 13, 2026 — Artera has announced the enrollment of the first patient in its DIRECT-AI registry study, marking the ...

Time August 14, 2026
arrow
Subscribe Now